WW

WW International, Inc.

WWHealthcareNASDAQ

Medical Care Facilities

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$710.6M
-9.6% YoY
Net Income
$1.06B
+405.5% YoY
EBITDA
$1.22B
+716.1% YoY
Free Cash Flow
$88.8M

Scan Results

Daily timeframe
DateIndicatorDetails
Oct 20CONFIRMED▲ RSI OversoldRSI 27.0, below 30, stock may be oversold
Oct 16▼ Below MA1500.4% below MA150
About WW International, Inc.

WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. Valued at $134.7M, WW is a micro-cap name in its sector. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause.

Where WW stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, WW finished 12.55% below its 150-day moving average ($14.58) and 24.33% below its 200-day moving average ($16.85). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is WW overbought or oversold?

At the October 20, 2026 close, WW's RSI(14) was 27.0, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$134.7M
P/E (TTM)0.12
Fwd P/E-577.37
EPS$108.84
52W Change-59.1%
Dividend Yield0.00%
ROE-30.7%
Analysis

On the balance sheet, WW has $101.5M in cash with $426.3M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $88.8M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at -30.7%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has pulled back from $889.6M (2023) to $710.6M (2025), a 20% decline worth watching.

Investors considering WW International, Inc. should weigh the typical risks associated with WW's sector, size, and financial profile against their own risk tolerance and investment objectives. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing WW.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms